Yu-wei Lin
Guangdong Provincial Key Laboratory Of New Drug Design And Evaluation
Guangzhou, 510006, China
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A novel NAMPT activator ameliorates obesity by repressing ACSL1-dependent lipid synthesis.
Journal: Acta pharmaceutica Sinica. B
Published: September 03, 2025
Identification of Indoquinazoline Derivatives as Novel NR4A1 Agonists by Suppressing Adipocyte Lipogenesis for Treatment of Obesity.
Journal: Journal of medicinal chemistry
Published: August 15, 2025
HSQC-guided discovery and structural optimization of antiadipogenic indole diterpenoids from endophytic fungus Penicillium janthinellum H-6.
Journal: European journal of medicinal chemistry
Published: May 23, 2025
Disrupting the protein-protein interaction network of Hsp72 inhibits adipogenic differentiation and lipid synthesis in adipocytes.
Journal: Cellular signalling
Published: July 29, 2024
L-aspartate ameliorates diet-induced obesity by increasing adipocyte energy expenditure.
Journal: Diabetes, obesity & metabolism
Published: July 25, 2024
Development of Novel N-Acylhydrazone Derivatives with High Anti-obesity Activity and Improved Safety by Exploring the Pharmaceutical Properties of Aldehyde Group.
Journal: Journal of medicinal chemistry
Published: July 12, 2024
Design, synthesis and structure-activity relationship of novel 2-pyrimidinylindole derivatives as orally available anti-obesity agents.
Journal: European journal of medicinal chemistry
Published: July 02, 2024
Design, synthesis and evaluation of 2-pyrimidinylindole derivatives as anti-obesity agents by regulating lipid metabolism.
Journal: European journal of medicinal chemistry
Published: July 12, 2023
Fluorescent Quinolinium Derivative as Novel Mitochondria Probe and Function Modulator by Targeting Mitochondrial RNA.
Journal: Molecules (Basel, Switzerland)
Published: February 17, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026